By Pharmadule Morimatsu…
To get in touch with Pharmadule Morimatsu AB, simply fill out the form below.
Subscribe to Supplier
Pharmadule Morimatsu brings world-leading process design skills to INTERPHEX 2017
Nacka, Stockholm: – Pharmadule Morimatsu AB, the Swedish-based world-wide turnkey supplier specialist in modular construction, facility engineering and in process equipment’s to the pharmaceutical, biotech, life sciences and other industries, will display its expertise in modular construction, facility engineering and process equipment at the high prestige INTERPHEX expo in New York.
Pharmadule is now accepting bookings for face-to-face meetings at INTERPHEX 2017 at its stand, Booth 3818, at New York’s Javits Center, where its team will present the company’s impressive portfolio of facility engineering, process equipment’s, quality by design (QbD), regulatory compliance and other disciplines.
Modular project expertise
It will demonstrate Pharmadule Morimatsu’s global leadership in the delivering innovative process equipment solutions including design and fabrication of vessels, bioreactors, heat exchangers, solution prep and CIP skids and assemblies together with modular project delivery.
Together, these strengths have helped Pharmadule win several landmark orders over the past few months as it enters its 30th Anniversary year, including a recent commissions for design studies in China and an order to produce designs for fast-moving consumer goods (FMCG) modular production facilities at two different global locations.
Total facility solutions
“We can provide our clients with a total facility and process equipment’s solution to meet any manufacturing need in any part of the world,” said Scott Kaplan, Pharmadule Morimatsu Senior Director for Project Development.
“Rapid off-site fabrication with innovative modular deployment that uses overlapping parallel activities reduces time-to-market while indoor fabrication in a highly controlled environment ensures highest quality for an optimized site installation,” Mr. Kaplan added.
“Our offer is the very embodiment of the INTERPHEX 2017 theme ‘Experience Science through Commercialization’ in that we actually specialize in providing the latest cutting-edge technologies needed to develop and manufacture quality products cost effectively,” he concluded.
About Pharmadule Morimatsu
Pharmadule Morimatsu designs and builds turnkey production facilities and process equipment’s for the pharma – biopharma Industries and also for the FMCG area (Fast Moving Consumer Goods). Pharmadule services extend from conceptual design to IQOQ qualifications completion, offering a one-stop-shop suite of services that include: Front-End Design & Pre-Engineering, Detailed Design, Fabrication, Quality Assurance (QA) and Validation Management.
The company was founded in September 1986 by engineer Clas Wallenborg whose vision was to use the same basic modular design techniques and technology used to build specialized spaces for offshore oil platforms to be able to deliver ‘ready made’ hygienic pharmaceutical production and laboratory facilities worldwide. These could be designed and fabricated centrally under hi-tech controlled conditions and transported to pharma sites all over the world for final assembly and erection.
Since then, Pharmadule has successfully delivered more than 60 production facilities worldwide for clients including Eli Lilly, Merck, Baxter, GlaxoSmithKline, Genentech, Pharmacia and AstraZeneca, forging The Pharmadule Way as a way of offering unique value and reassurance to customers, with off-site construction and modular design concepts to provide very high predictability of on time, on budget delivery and consistent high quality, regardless of final location.
Since 2011, Pharmadule has been part of the Morimatsu Group of Japan – specialized in process equipments, forming Pharmadule Morimatsu AB, headquartered in Stockholm, Sweden. The company also has a strong presence in Asia with engineering and manufacturing facilities in Shanghai, providing an enhanced service for clients in new markets.
About INTERPHEX 2017
After 38 years, America’s International Pharmaceutical Expo (INTERPHEX or IPX) has become one of the world’s leading single source events for biopharmaceutical and pharmaceutical manufacturing and processing solutions and technologies. The Expo aims to showcase the full range of state-of-the-art solutions needed for cost-effective product development and manufacture, including equipment, accessories and technologies while offering networking and peer-to-peer sharing opportunities, presentations and interactive demonstrations.
INTERPHEX 2017 is a three-day event opening April 21, once again at the Javits Center in New York City. The event is sponsored by the Parenteral Drug Association (PDA).
This year’s event will feature more than 620 vendors and is expected to attract some 10,500 pharmaceutical and biopharmaceutical industry professionals.
IPX is organized by organized by Reed Exhibitions with more information at: http://www.interphex.com